Sulforaphane: An emergent anti-cancer stem cell agent
Frontiers in Oncology · 23.01.2023 · 13
DOI: 10.3389/fonc.2023.1089115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 23.01.2023. Verfasst von Leandro de Lima Coutinho und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigação Translacional em Oncologia (LIM24), Departamento de Radiologia e Oncologia, Instituto do Câncer do Estado de São Paulo, Faculd…. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Cancer is a major public health concern worldwide responsible for high morbidity and mortality rates. Alternative therapies have been extensively investigated, and plant-derived compounds have caught the attention of the scientific community due to their chemopreventive and anticancer effects. Sulforaphane (SFN) is one of these naturally occurring agents, and studies have shown that it is able to target a specific cancer cell population displaying stem-like properties, known as cancer stem cells (CSCs). These cells can self-renewal and differentiate to form highly heterogeneous tumor masses. Notably, most of the conventional chemotherapeutic agents cannot target CSCs once they usually exist in a quiescent state and overall, the available cytotoxic drugs focus on highly dividing cells. This is, at least in part, one of the reasons why some oncologic patients relapse after standard therapy. In this review we bring together studies supporting not only the chemopreventive and anticancer properties of SFN, but especially the emerging anti-CSCs effects of this natural product and its potential to be used with conventional antineoplastic drugs in the clinical setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centro de Investigação Translacional em Oncologia (LIM24), Departamento de Radiologia e Oncologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brazil.
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Coutinho, L. L., Junior, T. C. T., & Rangel, M. C. (2023). Sulforaphane: An emergent anti-cancer stem cell agent. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1089115
Vancouver
Coutinho LL, Junior TCT, Rangel MC. Sulforaphane: An emergent anti-cancer stem cell agent. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1089115
BibTeX
@article{Coutinho2023,
author = {Coutinho, Leandro de Lima and Junior, Tharcísio Citrangulo Tortelli and Rangel, Maria Cristina},
title = {Sulforaphane: An emergent anti-cancer stem cell agent},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1089115}
}
EUVIMED